Literature DB >> 29956799

Effects of constrained dynamic loading, CKIP‑1 gene knockout and combination stimulations on bone loss caused by mechanical unloading.

Biao Han1, Shu-Ping Wei1, Xin-Chang Zhang2, Hao Li1, Yu Li2, Rui-Xin Li1, Kairen Li1, Xi-Zheng Zhang1.   

Abstract

Mechanical stimulation plays an important role in maintaining the growth and normal function of the skeletal system. Mechanical unloading occurs, for example, in astronauts spending long periods of time in space or in patients on prolonged bed rest, and causes a rapid loss of bone mass. Casein kinase 2‑interacting protein‑1 (CKIP‑1) is a novel negative bone regulation factor that has been demonstrated to reduce bone loss and enhance bone formation. The aim of this study was to investigate the effect of constrained dynamic loading (Loading) in combination with CKIP‑1 gene knockout (KO) on unloading‑induced bone loss in tail‑suspension mice. The blood serum metabolism index [alkaline phosphatase (ALP) activity and osteocalcin (OCN) levels], tibia mechanical behavior (including bone trabecular microstructure parameters and tibia biomechanical properties), osteoblast‑related gene expression [ALP, OCN, collagen I and bone morphogenetic protein‑2 and osteoprotegerin (OPG)] and osteoclast‑related gene expression [receptor activators of NF‑kB ligand (RANKL)] were measured. The results demonstrated that mice experienced a loss of bone mass after four weeks of tail suspension compared with a wild type group. The mechanical properties, microarchitecture and mRNA expression were significantly increased in mice after Loading + KO treatment (P<0.05). Furthermore, compared with loading or KO alone, the ratio of OPG/RANKL was increased in the combined treatment group. The combined effect of Loading + KO was greater than that observed with loading or KO alone (P<0.05). The present study demonstrates that Loading + KO can counter unloading‑induced bone loss, and combining the two treatments has an additive effect. These results indicate that combined therapy could be a novel strategy for the clinical treatment of disuse osteoporosis associated with space travel or bed rest.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29956799     DOI: 10.3892/mmr.2018.9222

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  The construction of a novel xenograft bovine bone scaffold, (DSS)6-liposome/CKIP-1 siRNA/calcine bone and its osteogenesis evaluation on skull defect in rats.

Authors:  Gang Xu; Xiantong Hu; Liwei Han; Yantao Zhao; Zhonghai Li
Journal:  J Orthop Translat       Date:  2021-03-02       Impact factor: 5.191

Review 2.  The Skeletal Cellular and Molecular Underpinning of the Murine Hindlimb Unloading Model.

Authors:  Priyanka Garg; Maura Strigini; Laura Peurière; Laurence Vico; Donata Iandolo
Journal:  Front Physiol       Date:  2021-10-19       Impact factor: 4.566

3.  The effect of QiangGuYin on osteoporosis through the AKT/mTOR/autophagy signaling pathway mediated by CKIP-1.

Authors:  Yifeng Yuan; Jiangang Sun; Hang Zhou; Shen Wang; Caijian He; Tianpeng Chen; Mouhao Fang; Shaohua Li; Shifa Kang; Xiaosheng Huang; Binbin Tang; Bocheng Liang; Yingdelong Mao; Jianyou Li; Xiaolin Shi; Kang Liu
Journal:  Aging (Albany NY)       Date:  2022-01-24       Impact factor: 5.682

Review 4.  Microgravity-Related Changes in Bone Density and Treatment Options: A Systematic Review.

Authors:  Ronni Baran; Markus Wehland; Herbert Schulz; Martina Heer; Manfred Infanger; Daniela Grimm
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

5.  Casein kinase 2 interacting protein 1 positively regulates caudal-related homeobox 1 in intestinal-type gastric cancer.

Authors:  Liang Ma; Ying Cao; Jian-Jun Hu; Ming-Liang Chu
Journal:  Chin Med J (Engl)       Date:  2020-01-20       Impact factor: 2.628

6.  High expression of the CKIP-1 gene might promote apoptosis through downregulation of the Ras/ERK signalling pathway in the intestinal type of gastric cancer.

Authors:  Liang Ma; Ying Cao; Jianjun Hu; Mingliang Chu
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.